Maintenance pemetrexed (Pem) plus best supportive care (BSC) versus placebo (Plac) plus BSC: A randomized phase III study in advanced non-small cell lung cancer (NSCLC)

作者：Chandra Prakash Belani, T. Brodowicz, T-E. Ciuleanu, J. H. Kim, Maciej Jerzy Krzakowski, Eckart Laack, Yi-Long Lung Cancer Wu, Patrick M. Peterson, Kurt Krejcy, C.C. Zielinski · 发表于：Journal of Clinical Oncology · 年份：2009 · DOI：10.1200/jco.2009.27.15_suppl.cra8000 · 被引用次数：82 · 研究领域：Lung Cancer Treatments and Mutations、Lung Cancer Diagnosis and Treatment、Lung Cancer Research Studies

CRA8000 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. [Table: see text]